SecBot SecBot
SC 13G ·Filed Nov 13, 2026

MEDP

Medpace Holdings, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed3d 15h ago SEC0001167557-26-000279
Passive investor 5%+ stake
Actionable Insight • Neutral

AQR's new 5% passive stake signals conviction from a quantitative manager, but as a 13G filer there is no activist intent. Monitor future 13G amendments for stake increases or a conversion to 13D, which would indicate a shift to active engagement. The filing follows Medpace's Q3 earnings beat and raised guidance, suggesting the position was built on improving fundamentals.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$653.94
T+0 close · Nov 13, 2026 · via day close
Latest settled
−0.88%
T+1 · $648.20
Vs SPY
+1.03%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $653.94entry
  2. T+1 · 18h ago −0.88%α +1.03% · $648.20
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

AQR Capital Management disclosed a 5.00% passive stake in Medpace Holdings via a new Schedule 13G filing, holding 1,396,654 shares as of September 30, 2026. This is a new position from a quantitative hedge fund, filed as passive with no intent to influence control. The stake is notable in size but passive, and follows Medpace's Q3 earnings beat and raised guidance, suggesting the position was built during a period of improving fundamentals.

Key Financial Metrics

Stake
5%
Investor
AQR Capital Management LLC
Investor Type
hedge fund

Key Facts

  • AQR Capital Management filed a new Schedule 13G disclosing beneficial ownership of 1,396,654 shares of Medpace common stock.
  • The stake represents 5.00% of shares outstanding as of September 30, 2026.
  • AQR certifies the shares were acquired and are held in the ordinary course of business, not for changing or influencing control.
  • AQR Capital Management, LLC is a wholly owned subsidiary of AQR Capital Management Holdings, LLC.
  • This is a new position; no prior 13G or 13D from AQR for Medpace was found in the provided context.

Financial Impact

Stake valued at approximately $930M based on market cap of $18.6B and 5.00% ownership.

ownership concentration

Risk Factors

  • AQR could increase or decrease the stake without public disclosure until the next 13G amendment threshold (change of 1%+ or year-end).
  • Passive filing status could change if AQR later engages with management, requiring conversion to 13D.
  • The stake is just above the 5% threshold; a reduction below 5% would not require immediate disclosure.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
35% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001167557-26-000279
Document: 0001167557-26-000279-index.html0001167557-26-000279
Document: 0001167557-26-000279.txt0001167557-26-000279

Track record

24 reports on MEDP

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +11.09% at T+20 after the Dec 4, 2025 report. 5 of 6 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $652.28 Now $648.20 +0.62% settles Nov 17
  2. Nov 13, 20263d ago SC 13G Neutral 4/10 Viewing Entry $653.94 to $648.20 Now $648.20 −0.88% ▼ −0.88% +1.03% vs SPY
  3. Nov 2, 202614d ago Insider Cluster Bearish 4/10 Entry $663.49 to $656.77 Now $648.20 +2.30% ▲ +1.01% +2.66% vs SPY
  4. Oct 29, 202618d ago 144 Neutral 2/10 Entry $677.56 to $652.01 Now $648.20 −4.33% ▼ −3.77% −2.00% vs SPY
  5. Oct 27, 202620d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
  6. Oct 26, 202621d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
  7. Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $669.20 to $676.77 Now $648.20 −3.14% ▲ +1.13% +0.42% vs SPY
  8. Oct 21, 202626d ago 8-K Bullish 6/10 Entry $653.96 to $669.20 Now $648.20 −0.88% ▲ +2.33% +2.85% vs SPY
  9. Sep 28, 20267w ago SC 13D/A Neutral 4/10 Entry $622.11 to $624.18 Now $648.20 +4.19% ▲ +0.33% +0.54% vs SPY
  10. Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $583.21 to $593.02 Now $648.20 +11.14% ▲ +1.68% +1.24% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens in 8h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026